Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation - Cervarix, June 19, 2008

System Info - 94741  SHONE, DEANNA   20-May-2009 17:34:22  SHONEDE



Submission Type: Original Application   Submission ID:  125259/0    Office: OVRR  


Human Papillomavirus Vaccine, AS04 Adjuvant-Adsorbed


GlaxoSmithKline Biologicals          

Telecon Date/Time:  19-JUN-2008 12:00 AM               Initiated by FDA?  Yes

Telephone Number:    

Communication Categorie(s):



Telecon Summary:

Email: Communication BLA 125259/0

FDA Participants:  

Non-FDA Participants:   

Trans-BLA Group: No

Related STNs:  None

Related PMCs:  None

Telecon Body:

From:                     Gemignani, Helen S 

Sent:                      Thursday, June 19, 2008 6:47 AM

To:                          ''

Cc:                          ''

Subject:                June 19 Communication BLA 125259/0 - Upload to EDR


We have the following items to present to GSK for brief discussion at our meeting on Tuesday:

1)  CBER requests that safety reports submitted to IND -b(4)-, after December 31, 2007, also be submitted to the BLA 125259.

2)  CBER requests that monthly updates of number of doses distributed of Cervarix by country (EU, Mexico, Australia, Singapore, and Philippines) be submitted to the BLA. 


Helen Sullivan Gemignani

Regulatory Project Manager

Division of Vaccines and Related Products Applications

Office of Vaccines Research and Review

Center for Biologics Evaluation and Research

Food and Drug Administration

(301) 827-3070

Page Last Updated: 04/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English